DNMT1 is associated with QDPR downregulation and chemotherapy response in lung adenocarcinoma
Functional and drug sensitivity experiments further support the potential of DNMT1 as a therapeutic target for improving the response to platinum-based chemotherapy in a subset of patients with LUAD and provide mechanistic insights into treatment response heterogeneity and chemoresistance in LUAD.